LGND · Ligand Pharmaceuticals Inc

$288.01 -8.27 (-2.79%) At close · Jul 29

Market Cap

$5.94B

20.04M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Todd C. Davis	CEO	$724,500	—	$5,520,493	$4,441,120	$764,400	$21,582	$11,472,095
Tavo Espinoza	CFO	$522,825	—	$1,932,219	$1,554,411	$357,750	$14,943	$4,382,148
Andrew Reardon	Chief Legal Officer and Secretary	$476,675	—	$1,656,171	$1,332,345	$268,800	$13,291	$3,747,282

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Matthew Korenberg	COO	$385,545	—	$6,716,643	$5,802,366	$142,789	$118,326	$13,165,669
Todd C. Davis	CEO	$695,834	—	$6,429,536	$5,142,650	$637,000	$9,960	$12,914,980
Tavo Espinoza	CFO	$469,550	—	$1,428,806	$1,142,820	$250,000	$7,380	$3,298,556
Andrew Reardon	Chief Legal Officer and Secretary	$451,950	—	$1,428,806	$1,142,820	$240,000	$7,380	$3,270,956

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Todd C. Davis	CEO	$650,007	—	$3,378,456	$1,788,095	$390,000	$9,960	$6,216,518
Matthew Korenberg	COO	$549,912	—	$1,801,880	$953,640	$274,956	$6,900	$3,587,288
Tavo Espinoza	CFO	$433,005	—	$1,201,271	$635,773	$173,202	$7,380	$2,450,631
Andrew Reardon	Chief Legal Officer and Secretary	$434,262	—	$1,126,169	$596,045	$173,705	$6,900	$2,337,081

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
John Higgins	CEO	$675,264	—	$4,562,984	$5,178,758	—	$6,347,984	$16,764,990
Matthew Korenberg	COO	$519,858	—	$2,691,809	$3,089,749	$234,229	$6,900	$6,542,545
Todd C. Davis	CEO	$49,243	—	$79,607	$5,001,298	—	$65,021	$5,195,169
Matthew Foehr	COO	$451,057	—	$2,041,319	$1,400,037	—	$115,353	$4,007,766
Tavo Espinoza	CFO	$330,097	—	$1,385,048	$1,430,012	$119,715	$7,380	$3,272,252
Andrew Reardon	Chief Legal Officer and Secretary	$172,917	—	$1,023,470	$1,746,108	$62,250	$2,909	$3,007,654
Charles S. Berkman	General Counsel	$396,920	—	$1,200,811	$823,556	—	$12,150	$2,433,437

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
John Higgins	CEO	$696,583	—	$6,016,298	$2,344,512	$522,438	$7,380	$9,587,211
Matthew Korenberg	COO	$497,297	—	$4,890,114	$1,082,118	$248,649	$7,300	$6,725,479
Matthew Foehr	COO	$518,933	—	$3,146,844	$1,226,357	$259,467	$130,603	$5,282,204
Charles S. Berkman	General Counsel	$451,682	—	$1,665,811	$649,308	$203,257	$10,890	$2,980,948

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
John Higgins	CEO	$668,333	—	$2,277,460	$2,389,544	$501,250	$6,180	$5,842,767
Matthew Foehr	COO	$503,750	—	$1,242,269	$1,303,366	$277,063	$158,001	$3,484,449
Matthew Korenberg	COO	$482,833	—	$1,150,224	$1,206,821	$265,558	$5,700	$3,111,136
Charles S. Berkman	General Counsel	$441,917	—	$644,168	$675,820	$176,767	$6,180	$1,944,852

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
John Higgins	CEO	$648,192	—	$2,933,389	$2,891,109	$291,686	$6,000	$6,770,376
Matthew Foehr	COO	$487,500	—	$1,711,163	$1,686,480	$195,000	$164,766	$4,244,909
Matthew Korenberg	CFO	$466,667	—	$1,466,580	$1,445,555	$186,667	$5,734	$3,571,203
Charles S. Berkman	General Counsel	$427,620	—	$733,290	$722,777	$136,933	$6,547	$2,027,167

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
John Higgins	CEO	$627,413	—	$2,779,081	$2,376,729	$517,615	$5,965	$6,306,803
Matthew Foehr	COO	$458,931	—	$1,361,147	$1,164,133	$252,412	$87,517	$3,324,140
Matthew Korenberg	CFO	$428,438	—	$1,077,560	$921,591	$235,641	$5,400	$2,668,630
Charles S. Berkman	General Counsel	$402,500	—	$623,961	$533,547	$177,100	$6,471	$1,743,579

Fiscal 2017

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
John Higgins	CEO	$611,656	$30,000	$2,111,154	$2,202,412	$550,491	$7,494	$5,513,207
Matthew Foehr	COO	$442,094	$30,000	$1,387,985	$1,280,493	$265,256	$52,675	$3,458,503
Matthew Korenberg	CFO	$403,438	$30,000	$736,550	$768,266	$242,063	$5,400	$2,185,717
Charles S. Berkman	General Counsel	$362,812	—	$466,461	$486,593	$174,150	$8,803	$1,498,819

Executive changes

Person	Role	Change	Effective	Filed
Martine Zimmermann, Pharm.D.	member of the Board of Directors	Appointed	2026-06-05	2026-06-09
Stephen L. Sabba, M.D.	member of the Board of Directors	Appointed	2026-06-05	2026-06-09
John L. LaMattina, Ph.D.	member of the Board of Directors	Appointed	2026-06-05	2026-06-09
John W. Kozarich, Ph.D.	member of the Board of Directors	Appointed	2026-06-05	2026-06-09
Jason Haas	member of the Board of Directors	Appointed	2026-06-05	2026-06-09
Nancy R. Gray, Ph.D.	member of the Board of Directors	Appointed	2026-06-05	2026-06-09
Todd C. Davis	member of the Board of Directors	Appointed	2026-06-05	2026-06-09
Jason M. Aryeh	member of the Board of Directors	Appointed	2026-06-05	2026-06-09

Key facts CIK 886163 CUSIP 53220K504 13F (30d) 117 filings 114 filers Visit website Investor relations